ES8605818A1 - Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina - Google Patents

Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina

Info

Publication number
ES8605818A1
ES8605818A1 ES539349A ES539349A ES8605818A1 ES 8605818 A1 ES8605818 A1 ES 8605818A1 ES 539349 A ES539349 A ES 539349A ES 539349 A ES539349 A ES 539349A ES 8605818 A1 ES8605818 A1 ES 8605818A1
Authority
ES
Spain
Prior art keywords
compound according
acetyl
erythromycin
compositions containing
stearate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539349A
Other languages
English (en)
Spanish (es)
Other versions
ES539349A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Publication of ES8605818A1 publication Critical patent/ES8605818A1/es
Publication of ES539349A0 publication Critical patent/ES539349A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
ES539349A 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina Expired ES8605818A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
ES8605818A1 true ES8605818A1 (es) 1986-04-01
ES539349A0 ES539349A0 (es) 1986-04-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539349A Expired ES8605818A1 (es) 1984-01-06 1985-01-04 Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina

Country Status (38)

Country Link
US (1) US4599326A (2)
JP (1) JPS60158197A (2)
KR (1) KR900006237B1 (2)
AT (1) AT386414B (2)
AU (1) AU565688B2 (2)
BE (1) BE901411A (2)
BG (1) BG43189A3 (2)
CA (1) CA1224461A (2)
CH (1) CH666275A5 (2)
CS (1) CS247191B2 (2)
CY (1) CY1462A (2)
DE (1) DE3500179A1 (2)
DK (1) DK149776C (2)
ES (1) ES8605818A1 (2)
FI (1) FI77249C (2)
FR (1) FR2557878B1 (2)
GB (1) GB2152502B (2)
HK (1) HK11590A (2)
HU (1) HU196221B (2)
IE (1) IE57967B1 (2)
IL (1) IL73885A (2)
IS (1) IS2968A7 (2)
IT (1) IT1184304B (2)
KE (1) KE3841A (2)
LU (1) LU85721A1 (2)
MA (1) MA20316A1 (2)
MX (1) MX156277A (2)
NL (1) NL8403979A (2)
NO (1) NO160263C (2)
NZ (1) NZ210606A (2)
PH (1) PH22471A (2)
PL (1) PL144349B1 (2)
PT (1) PT79777B (2)
RO (1) RO91262B (2)
SE (1) SE461854B (2)
SU (1) SU1410866A3 (2)
YU (1) YU44485B (2)
ZA (1) ZA8410143B (2)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル, インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP1677759A1 (en) * 2003-10-31 2006-07-12 Alza Corporation Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
WO2007149096A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Inc. Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN103796666B (zh) 2011-05-18 2018-07-06 欧莫德里斯制药公司 改良的肽药物
DK2922877T3 (da) 2012-11-20 2019-01-02 Eumederis Pharmaceuticals Inc Forbedrede peptidlægemidler
CN104918961A (zh) 2012-11-20 2015-09-16 梅德瑞斯糖尿病有限责任公司 用于胰岛素抗性的改良的肽药物
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
CN117180445A (zh) 2014-05-28 2023-12-08 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
KR20200010343A (ko) 2017-05-19 2020-01-30 루넬라 바이오테크 인코포레이티드 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
PL3678649T3 (pl) 2018-02-06 2023-05-08 Aegis Therapeutics, Llc Donosowe formulacje epinefryny i sposoby leczenia choroby
CN113453690A (zh) * 2018-12-17 2021-09-28 卢内拉生物技术有限公司 用于抗衰老的三联疗法
AU2019403048B2 (en) * 2018-12-17 2025-01-23 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FI77249C (fi) 1989-02-10
IT8519012A0 (it) 1985-01-04
RO91262A (ro) 1987-06-30
HU196221B (en) 1988-10-28
DK5884A (da) 1985-07-07
FR2557878B1 (fr) 1988-01-15
DE3500179A1 (de) 1985-07-18
FI850023A0 (fi) 1985-01-03
CY1462A (en) 1989-07-21
GB8432368D0 (en) 1985-02-06
HUT37628A (en) 1986-01-23
KR900006237B1 (ko) 1990-08-27
IE57967B1 (en) 1993-06-02
DK149776C (da) 1987-04-21
ES539349A0 (es) 1986-04-01
MA20316A1 (fr) 1985-10-01
RO91262B (ro) 1987-07-01
IL73885A0 (en) 1985-03-31
SE8406671D0 (sv) 1984-12-28
ATA985A (de) 1988-01-15
GB2152502B (en) 1987-10-07
PH22471A (en) 1988-09-12
IT1184304B (it) 1987-10-28
CH666275A5 (de) 1988-07-15
NO850007L (no) 1985-07-08
JPH029040B2 (2) 1990-02-28
NO160263B (no) 1988-12-19
NO160263C (no) 1989-03-29
CA1224461A (en) 1987-07-21
BG43189A3 (en) 1988-04-15
PT79777A (en) 1985-01-01
IL73885A (en) 1988-10-31
SE8406671L (sv) 1985-07-07
KE3841A (en) 1989-04-07
FI850023L (fi) 1985-07-07
HK11590A (en) 1990-02-23
YU44485B (en) 1990-08-31
PT79777B (en) 1986-10-21
PL251457A1 (en) 1985-11-05
KR850005452A (ko) 1985-08-26
DK149776B (da) 1986-09-29
MX156277A (es) 1988-08-04
AU565688B2 (en) 1987-09-24
FI77249B (fi) 1988-10-31
IS2968A7 (is) 1985-04-03
CS247191B2 (en) 1986-12-18
SU1410866A3 (ru) 1988-07-15
GB2152502A (en) 1985-08-07
SE461854B (sv) 1990-04-02
ZA8410143B (en) 1985-08-28
US4599326A (en) 1986-07-08
LU85721A1 (fr) 1985-07-24
NZ210606A (en) 1987-08-31
AU3705984A (en) 1985-07-11
DE3500179C2 (2) 1989-08-24
NL8403979A (nl) 1985-08-01
YU2085A (en) 1987-12-31
AT386414B (de) 1988-08-25
DK5884D0 (da) 1984-01-06
PL144349B1 (en) 1988-05-31
IE850022L (en) 1985-07-06
FR2557878A1 (fr) 1985-07-12
JPS60158197A (ja) 1985-08-19
BE901411A (fr) 1985-04-16

Similar Documents

Publication Publication Date Title
ES8605818A1 (es) Un metodo para la preparacion del compuesto antibiotico, estearato de acetil-eritromicina
ES9000023A1 (es) Un procedimiento para preparar nuevos antibioticos macrociclicos que contienen anillos de dihidrobenzofurano y de pirano
IL91159A0 (en) Tetrahydro-1-benz-(c,d)-indole-propionic acid sulphonamides,their preparation and pharmaceutical compositions containing them
KR850004246A (ko) 헤테로-폴리사이클 방향족 화합물의 제법
RU2051919C1 (ru) Соединения пенема и фармацевтическая композиция на их основе
GB1488420A (en) Aminoglycosides
US5142042A (en) Process for preparing well crystallized alkali metal salts of 3, 7-substituted 7-aminocephalosporanic acid derivatives
ES8105253A1 (es) Procedimiento para preparar acidos fenilalcanoicos.
GB1525626A (en) Tetrazolethiomethyl cephalosporin compounds
GB1478281A (en) 11,12-secoprostaglandins
ES8404326A1 (es) Un procedimiento para preparar el nuevo compuesto ester guayacilico del acido 1-metil-5-p-toluilpirrol-2-acetico.
ES8307236A1 (es) Un procedimiento para la preparacion de ranitidina.
HK46190A (en) Catechol derivatives
IE45436L (en) 12-azaprostanoic acid derivatives
SE8303727L (sv) Cefalosporinantibiotika
IE44230L (en) 1, 3-diaza-bicyclo [3,2, 0] heptane derivatives
GB2009158A (en) Thienylmalonic Acid and Diesters Thereof
IE44698L (en) Cephalosporins.
EP0381915B1 (en) Process for preparing alkali metal salts of 3,7-substituted 7-aminocephalosporanic acid derivatives.
IE42705L (en) Cephalosporin compounds.
JPS5653682A (en) Production of novel rifamycin derivative
JPS5427546A (en) Liquid crystal compound
GB2012260A (en) 4-desacetoxy-4 alpha -hydroxyindole- dihydroindoles, pharmaceutical formulations containing them and their use as antimitotic agents
KR880002879A (ko) (5r,6s,8r)-6-(1-하이드록시에틸)-2-(3r-피롤리딘-2-온-3-일) 티오페넴-3-카복실산
IE38377B1 (en) Maleopimarimide derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401